Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;54(5):992-996.
doi: 10.1016/j.jmii.2020.08.010. Epub 2020 Aug 20.

Olfactory disorder in patients infected with SARS-CoV-2

Affiliations

Olfactory disorder in patients infected with SARS-CoV-2

Yung-Feng Yen et al. J Microbiol Immunol Infect. 2021 Oct.

Abstract

Three (60%) of five patients with coronavirus disease 2019 (COVID-19) had olfactory disorder. Two exhibited anosmia at the onset of COVID-19, while one had hyposmia 4 days after the onset of COVID-19. All patients with olfactory disorder were completely recovered with a mean recovery length of 11.3 days.

Keywords: COVID-19; Olfactory disorder; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest No conflict of interest exists for the author.

Figures

Figure 1
Figure 1
Time course of olfactory disorder and RT-PCR assay in COVID-19 patients. Abbreviations: SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; RT-PCR, real-time reverse transcriptase–polymerase chain reaction; COVID-19, coronavirus disease 2019.

Similar articles

Cited by

References

    1. World Health Organization Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/
    1. Taiwan Centers for Disease Control and Prevention Surveillance of COVID-19. https://www.cdc.gov.tw/En
    1. Zou X., Chen K., Zou J., Han P., Hao J., Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020 Apr;14(2):185–192. - PMC - PubMed
    1. Fu Y., Cheng Y., Wu Y. Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin. 2020 Jun;35(3):266–271. - PMC - PubMed
    1. Eliezer M., Hautefort C., Hamel A.L., Verillaud B., Herman P., Houdart E. Sudden and complete olfactory loss function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. 2020 - PubMed